ampicillin has been researched along with Bone Loss, Osteoclastic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hanazawa, S; Kitano, S; Miyata, Y; Takeda, H | 1 |
| Allesandri, R; Friedman, SA; Shagan, BP | 1 |
2 other study(ies) available for ampicillin and Bone Loss, Osteoclastic
| Article | Year |
|---|---|
Porphyromonas gingivalis lipopolysaccharide-stimulated bone resorption via CD14 is inhibited by broad-spectrum antibiotics.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Bone Resorption; Chloramphenicol; Erythromycin; Gene Expression; Interleukin-1; Interleukin-6; Lipopolysaccharide Receptors; Lipopolysaccharides; Mice; Osteoclasts; Porphyromonas gingivalis; RNA, Messenger; Skull; Streptomycin; Tetracycline | 1997 |
Diabetic osteopathy: report of a relentlessly progressive case, with clinico-pathologic correlations.
Topics: Ampicillin; Amputation, Surgical; Bone Resorption; Calcaneus; Diabetic Neuropathies; Female; Fibula; Humans; Immobilization; Leg Ulcer; Median Nerve; Middle Aged; Necrosis; Neural Conduction; Peroneal Nerve; Radiography; Talus; Tibia; Tibial Nerve; Toes; Ulnar Nerve | 1973 |